Litcius/Paper detail

Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma

Chenhao Zhou, Jialei Weng, Chunxiao Liu, Shaoqing Liu, Zhiqiu Hu, Xiaoli Xie, Dongmei Gao, Qiang Zhou, Jialei Sun, Ru-Chen Xu, Hui Li, Ying‐Hao Shen, Yong Yi, Yi Shi, Xia Sheng, Qiongzhu Dong, Mien‐Chie Hung, Ning Ren

2023Gastroenterology114 citationsDOIOpen Access PDF

Topics & Concepts

Cancer researchChemokineGene knockdownMacrophage polarizationBiologyImmune systemHepatocellular carcinomaChemokine receptorCCL22ImmunologyApoptosisMacrophageIn vitroBiochemistryPARP inhibition in cancer therapyCancer Immunotherapy and BiomarkersGlioma Diagnosis and Treatment
Disruption of SLFN11 Deficiency–Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti–PD-1 Therapy Efficacy in Hepatocellular Carcinoma | Litcius